Related Experiment Video

Updated: Apr 27, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

3.5K

Effect of treatment of convulsive status epilepticus on outcome in children

T Shatirishvili1, N Tatishvili1, G Lomidze1

  • 1D. Tvildiani Medical University; M. Iashvili Children Central Hospital, Tbilisi, Georgia.

Georgian Medical News
|July 15, 2014
PubMed

Insights

Early treatment of convulsive status epilepticus (CSE) in children is crucial. Standardized pre-hospital care significantly improves outcomes, reducing seizure duration and the need for interventions like artificial ventilation.

Area of Science:

  • Pediatric Neurology
  • Emergency Medicine
  • Clinical Research

Background:

  • Convulsive Status Epilepticus (CSE) is a common pediatric neurological emergency.
  • Prompt intervention is critical for improving patient outcomes.
  • Existing guidelines exist, but their adaptation to local realities is important.

Purpose of the Study:

  • To evaluate the impact of pre-hospital and hospital treatment strategies on CSE outcomes in children.
  • To identify key determinants of seizure prolongation and patient outcomes.
  • To assess the influence of standardized treatment protocols on pediatric CSE management.

Main Methods:

  • Prospective, hospital-based study of 48 pediatric CSE patients.
  • Review of pre-hospital and hospital treatment strategies and outcomes.
  • Adaptation of the 'North Central London Epilepsy Network for Children & Young People' guideline.

Main Results:

  • Multiple benzodiazepine (BZD) doses correlated with increased artificial ventilation needs.
  • Timely and appropriate pre-hospital treatment was strongly linked to shorter CSE duration.
  • Delayed admission and multiple BZD doses were key factors in prolonged seizures.

Conclusions:

  • Lack of standardized pre-hospital treatment for pediatric CSE negatively impacts outcomes.
  • Timely initiation of appropriate treatment is vital for effective CSE management.
  • Optimizing pre-hospital care can significantly improve the prognosis for children with CSE.

More Related Videos

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

22.8K
Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

17.1K

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.5K
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
33
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.4K
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
30
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K